Contact us to find out how we can help you
For researchers in MRC Units and Institutes
MRC researchers should contact the Business Manager allocated to their Unit or Institute.
If you’re not sure who your Business Manager is, please Contact Us and we’ll put you in touch with the right person.
For researchers in other organisations
Researchers in other organisations should contact their local technology transfer office in the first instance.
News feed
MRCT are collaborating with the University of Bristol to develop orally available small molecule TrkA antagonists for treatment of chronic intractable pain.
MRC Technology’s Therapeutic Antibody Group and The University of Aberdeen work together on project to develop therapeutic against a novel cancer target, soluble CTLA-4.
Aptuscan, a spin out company based on research carried out at the MRC Cancer Cell Unit, has been acquired by Avacta, an AIM-listed biotechnology company.
MRC Technology announced today that they have entered into an agreement with the Association for International Cancer Research (AICR) to assist in the oversight and management of intellectual property (IP) arising from AICR-funded projects.